Glenview Trust’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-23,097
Closed -$615K – 477
2023
Q4
$615K Buy
+23,097
New +$582K 0.02% 308

Other funds holding FTXH

Glenview Trust's FTXH Position: Q1 2024 in Review

Glenview Trust sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2024, closing a stake of 23,097 shares — an estimated $615K sold.

Glenview Trust first reported a position in FTXH in Q4 2023 and held it in 1 quarter. The position peaked at $615K in Q4 2023. 19 funds tracked by Wall St. Rank hold FTXH as of Q1 2024.

  • Glenview Trust reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
  • Glenview Trust sold 23,097 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2024, an estimated $615K.
  • Glenview Trust first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2023 and held it in 1 quarter.
  • Glenview Trust's First Trust Nasdaq Pharmaceuticals ETF position peaked at $615K in Q4 2023.
  • 19 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2024.

Based on Glenview Trust's 13F filing for Q1 2024, filed 14 May 2024.